By Sheena Cruickshank, University of Manchester and Jonathan Worboys, for The ConversationA new immunotherapy drug has demonstrated early promise in a recent prostate cancer clinical trial. The drug, ...
The GPS Mdx test is a 17-gene expression assay performed on prostate biopsy tissue that may identify signals of favorable vs unfavorable pathology.
14h
HKSH Cancer Centre's Precision Targeting Technologies Leading the Evolution of "Hypofractionation"
HKSH Medical Group (HKSH) today announced the results of Asia's first clinical study on early-stage prostate cancer patients receiving five-session of proton therapy.* The results show significant ...
The latest stats on cancer death rates in the UK offer encouraging news – and further progress against the disease is within ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results